|
ROMO1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.10489999999242E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.380200E-04 |
| Normal-vs-Stage2 |
9.780300E-03 |
| Normal-vs-Stage3 |
2.429000E-04 |
| Normal-vs-Stage4 |
1.168310E-02 |
| Stage1-vs-Stage2 |
4.702600E-01 |
| Stage1-vs-Stage3 |
2.169000E-01 |
| Stage1-vs-Stage4 |
5.745200E-01 |
| Stage2-vs-Stage3 |
9.083800E-01 |
| Stage2-vs-Stage4 |
3.290600E-01 |
| Stage3-vs-Stage4 |
1.367990E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.594990E-04 |
| Normal-vs-AfricanAmerican |
6.864100E-02 |
| Normal-vs-Asian |
6.255800E-03 |
| Caucasian-vs-AfricanAmerican |
4.322600E-01 |
| Caucasian-vs-Asian |
9.700800E-01 |
| AfricanAmerican-vs-Asian |
5.612000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.578900E-04 |
| Normal-vs-Female |
1.809680E-04 |
| Male-vs-Female |
4.676200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.225300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.141760E-03 |
| Normal-vs-Age(61-80Yrs) |
2.021600E-03 |
| Normal-vs-Age(81-100Yrs) |
6.713600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.395000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.008400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.757800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.312200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.254000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.490400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.661400E-01 |
| Classical-VS-Follicular |
3.412100E-02 |
| Classical-VS-Other |
5.356800E-01 |
| Classical-VS-Normal |
1.162200E-03 |
| Tall-VS-Follicular |
1.835420E-01 |
| Tall-VS-Other |
5.947600E-01 |
| Tall-VS-Normal |
1.512820E-01 |
| Follicular-VS-Other |
8.334800E-01 |
| Follicular-VS-Normal |
6.08140000000201E-05 |
| Other-VS-Normal |
4.582400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.87623999999831E-05 |
| Normal-vs-N1 |
7.957500E-04 |
| N0-vs-N1 |
6.246000E-01 |
|
|
